What is NDC 51672-4174?

51672-4174 is the product NDC for Imiquimod, Imiquimod 37.5 mg/g cream, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Imiquimod?

10 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Imiquimod NDC 51672-4174 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-4174Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-4174Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51672-4174-6	5167241740651672417406	28 PACKET in 1 CARTON (51672-4174-6) / .25 g in 1 PACKET (51672-4174-8)Marketed from Jan 26, 2021
51672-4174-9	5167241740951672417409	1 BOTTLE, PUMP in 1 CARTON (51672-4174-9) / 7.5 g in 1 BOTTLE, PUMPMarketed from Oct 14, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Imiquimod
Generic name (nonproprietary): imiquimod
Active ingredients: Imiquimod — 37.5 mg/g
Dosage form: Cream
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.NDC labeler code 51672
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205971
Marketing start: Jan 26, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Increased Cytokine Activity (Physiologic effect)Increased Cytokine Production (Physiologic effect)Interferon Inducers (Mechanism)
Identifiers: Product ID 51672-4174_48e9d045-e9a2-8452-e063-6294a90af1e9SPL ID 48e9d045-e9a2-8452-e063-6294a90af1e9SPL set ID 51913a5a-1cab-4b9e-b2c2-e0174062df73RxCUI 967017UNII P1QW714R7MUPC 0351672417499

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672417406 followed by a unit qualifier and the quantity

Package 51672-4174-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2026.

Indications (excerpt from the label)

Imiquimod cream, 3.75% is indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. (1.1) • Imiquimod cream, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age or older. (1.2) 1.1 Actinic Keratosis Imiquimod cream, 3.75% is indicated for the topical treatment of clinically typical, visible or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. 1.2 External Genital Warts Imiquimod cream, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51672-4174

What is NDC 51672-4174?: 51672-4174 is the product NDC for Imiquimod, Imiquimod 37.5 mg/g cream, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Imiquimod.
What is the active ingredient?: Imiquimod.
Who is the labeler?: Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Imiquimod?: 10 other product NDCs are listed under this name. See all Imiquimod NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Imiquimod NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Imiquimod	Imiquimod 37.5 mg/g	CreamTopical	Anvi Pharmaceuticals Inc.	87519-004	87519-0004-75
Imiquimod	Imiquimod 37.5 mg/g	CreamTopical	Teva Pharmaceuticals USA, Inc.	0093-3133	00093-3133-31
Imiquimod	Imiquimod 12.5 mg/.25g	CreamTopical	DIRECT RX	72189-084	72189-0084-24
Imiquimod	Imiquimod 37.5 mg/g	CreamTopical	Oceanside Pharmacueticals	68682-272	68682-0272-75
Imiquimod	Imiquimod 50 mg/g	CreamTopical	Glenmark Pharmaceuticals Inc., USA	68462-536	68462-0536-70
Imiquimod	Imiquimod 50 mg/g	CreamTopical	Sun Pharmaceutical Industries, Inc.	51672-4145	51672-4145-06
Imiquimod	Imiquimod 12.5 mg/.25g	CreamTopical	Padagis Israel Pharmaceuticals Ltd	45802-368	45802-0368-5345802-0368-62
Imiquimod	Imiquimod 12.5 mg/.25g	CreamTopical	Bryant Ranch Prepack	71335-2725	71335-2725-01
Imiquimod	Imiquimod 12.5 mg/.25g	CreamTopical	Bryant Ranch Prepack	71335-3000	71335-3000-01
Imiquimod	Imiquimod 12.5 mg/.25g	CreamTopical	Bryant Ranch Prepack	72162-2332	72162-2332-02

Other NDCs under ANDA 205971

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205971
Product	Strength	Form · route	Labeler	Product NDC
Imiquimod	Imiquimod 37.5 mg/g	CreamTopical	Anvi Pharmaceuticals Inc.	87519-004